Frequency of PML-RARA and CBFB-MYH11 in Iraqi Patients with Acute Myeloid Leukemia
Abstract
Author(s): Rafal F. J. Aleiqabie, Fahrul Huyop, Ahmed D. Jabbar
Leukemia is a type of cancer that can be extremely aggressive, developing quickly and wreaking havoc on the body. This happens when genetic defects cause blood cell-producing cells in the bone marrow to divide uncontrollably. Because leukemia is heavily influenced by genetics, understanding the genetic material rearrangements that because cancer is key to improving treatment strategies. That's where this study comes in: by using advanced techniques like nested PCR and flow cytometry, researchers aimed to determine the frequency of two common fusion genes, PML-RARA and CBFB-MYH11, in Iraqi patients with acute myeloid leukemia. The results were striking, with PML-RARA showing a frequency of 10.00% and CBFB-MYH11 following closely behind with 5.71%. This groundbreaking research sheds light on the type of leukemia affecting Iraqi patients and could help pave the way for new and improved treatment options
Share this article
Editors List
-
Prof. Elhadi Miskeen
Obstetrics and Gynaecology Faculty of Medicine, University of Bisha, Saudi Arabia
-
Ahmed Hussien Alshewered
University of Basrah College of Medicine, Iraq
-
Sudhakar Tummala
Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh
-
Alphonse Laya
Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis
-
Fava Maria Giovanna
Google Scholar citation report
Citations : 208
Onkologia i Radioterapia received 208 citations as per Google Scholar report
Onkologia i Radioterapia peer review process verified at publons
Indexed In
- Directory of Open Access Journals
- Scimago
- SCOPUS
- EBSCO A-Z
- MIAR
- Euro Pub
- Google Scholar
- Medical Project Poland
- PUBMED
- Cancer Index
- Gdansk University of Technology, Ministry Points 20